Berer, K., Gerdes, L.A., Cekanaviciute, E., Jia, X., Xiao, L., Xia, Z., Liu, C., Klotz, L., Stauffer, U., Baranzini, S.E., Kümpfel, T., Hohlfeld, R., Krishnamoorthy, G. and Wekerle, H., 2017. Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice. Proceedings of the National Academy of Science of the USA 114: 10719-10724.

'Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice ' () 114 Proceedings of the National Academy of Science of the USA : 10719 -10724.

Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in miceProceedings of the National Academy of Science of the USA1141071910724)| false
• Search Google Scholar

Bircher, L., Schwab, C., Geirnaert, A. and Lacroix, C., 2018. Cryopreservation of artificial gut microbiota produced with in vitro fermentation technology. Microbial Biotechnology 11: 163-175.

'Cryopreservation of artificial gut microbiota produced with in vitro fermentation technology ' () 11 Microbial Biotechnology : 163 -175.

Cryopreservation of artificial gut microbiota produced with in vitro fermentation technologyMicrobial Biotechnology11163175)| false
• Search Google Scholar

Borody, T.J., Leis, S.M., Campbell, J., Torres, M. and Nowak, A., 2011. Fecal microbiota transplantation (FMT) in multiple sclerosis (MS). American Journal of Gastroenterology 106: S352.

'Fecal microbiota transplantation (FMT) in multiple sclerosis (MS) ' () 106 American Journal of Gastroenterology : S352.

Fecal microbiota transplantation (FMT) in multiple sclerosis (MS)American Journal of Gastroenterology106S352)| false
• Search Google Scholar

Burnard, S., Lechner-Scott, J. and Scott, R.J., 2017. EBV and MS: major cause, minor contribution or red-herring? Multiple Sclerosis Related Disorders 16: 24-30.

'EBV and MS: major cause, minor contribution or red-herring? ' () 16 Multiple Sclerosis Related Disorders : 24 -30.

EBV and MS: major cause, minor contribution or red-herring?Multiple Sclerosis Related Disorders162430)| false
• Search Google Scholar

Buscarinu, M.C., Cerasoli, B., Annibali, V., Policano, C., Lionetto, L., Capi, M., Mechelli, R., Romano, S., Fornasiero, A., Mattei, G., Piras, E., Angelini, D.F., Battistini, L., Simmaco, M., Umeton, R., Salvetti, M. and Ristori, G., 2017. Altered intestinal permeability in patients with relapsing-remitting multiple sclerosis: a pilot study. Multiple Sclerosis 23: 442-446.

'Altered intestinal permeability in patients with relapsing-remitting multiple sclerosis: a pilot study ' () 23 Multiple Sclerosis : 442 -446.

Altered intestinal permeability in patients with relapsing-remitting multiple sclerosis: a pilot studyMultiple Sclerosis23442446)| false
• Search Google Scholar

Cammarota, G., Ianiro, G., Tilg, H., Rajilić-Stojanović, M., Kump, P., Satokari, R., Sokol, H., Arkkila, P., Pintus, C., Hart, A., Segal, J., Aloi, M., Masucci, L., Molinaro, A., Scaldaferri, F., Gasbarrini, G., Lopez-Sanroman, A., Link, A., De Groot, P., De Vos, W.M., Högenauer, C., Malfertheiner, P., Mattila, E., Milosavljević, T., Nieuwdorp, M., Sanguinetti, M., Simren, M., Gasbarrini, A. and European FMT Working Group, 2017. European consensus conference on faecal microbiota transplantation in clinical practice. Gut 66: 569-580.

'European consensus conference on faecal microbiota transplantation in clinical practice ' () 66 Gut : 569 -580.

European consensus conference on faecal microbiota transplantation in clinical practiceGut66569580)| false
• Search Google Scholar

Cekanaviciute, E., Yoo, B.B., Runia, T.F., Debelius J.W., Singh, S., Nelson, C.A., Kanner, R., Bencosme, Y., Lee, Y.K., Hauser, S.L., Crabtree-Hartman, E., Sand, I.K., Gacias, M., Zhu, Y., Casaccia, P., Cree, B.A.C., Knight, R., Mazmanian, S.K. and Baranzini, S.E., 2017. Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbatesymptoms in mouse models. Proceedings of the National Academy of Science of the USA 114: 10713-10718.

'Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbatesymptoms in mouse models ' () 114 Proceedings of the National Academy of Science of the USA : 10713 -10718.

Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbatesymptoms in mouse modelsProceedings of the National Academy of Science of the USA1141071310718)| false
• Search Google Scholar

Chapman, B.C., Moore, H.B., Overbey, D.M., Morton, A.P., Harnke, B., Gerich, M.E. and Vogel, J.D., 2016. Fecal microbiota transplant in patients with Clostridium difficile infection: a systematic review. Journal of Trauma Acute Care Surgery 81: 756-764.

'Fecal microbiota transplant in patients with Clostridium difficile infection: a systematic review ' () 81 Journal of Trauma Acute Care Surgery : 756 -764.

Fecal microbiota transplant in patients with Clostridium difficile infection: a systematic reviewJournal of Trauma Acute Care Surgery81756764)| false
• Search Google Scholar

Chen, J., Chia, N., Kalari, K.R., Yao, J.Z., Novotna, M., Soldan, M.M., Luckey, D.H., Marietta, E.V., Jeraldo, P.R., Chen, X., Weinshenker, B.G., Rodriguez, M., Kantarci, O.H., Nelson, H., Murray, J.A. and Mangalam, A.K., 2016. Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Scientific Reports 27: 28484.

'Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls ' () 27 Scientific Reports : 28484.

Multiple sclerosis patients have a distinct gut microbiota compared to healthy controlsScientific Reports2728484)| false
• Search Google Scholar

Cohen, N.A. and Maharshak, N., 2017. Novel indications for fecal microbial transplantation: update and review of the literature. Digestive Disease and Science 62: 1131-1145.

'Novel indications for fecal microbial transplantation: update and review of the literature ' () 62 Digestive Disease and Science : 1131 -1145.

Novel indications for fecal microbial transplantation: update and review of the literatureDigestive Disease and Science6211311145)| false
• Search Google Scholar

Correale, J. and Farez, M.F., 2011. The impact of environmental infections (parasites) on MS activity. Multiple Sclerosis 17: 1162-1169.

'The impact of environmental infections (parasites) on MS activity ' () 17 Multiple Sclerosis : 1162 -1169.

The impact of environmental infections (parasites) on MS activityMultiple Sclerosis1711621169)| false
• Search Google Scholar

Cosorich, I., Dalla-Costa, G., Sorini, C., Ferrarese, R., Messina, M.J., Dolpady, J., Radice, E., Mariani, A., Testoni, P.A., Canducci, F., Comi, G., Martinelli, V. and Falcone, M., 2017. High frequency of intestinal TH17 cells correlates with microbiota alterations and disease activity in multiple sclerosis. Science Advances 3: e1700492.

'High frequency of intestinal TH17 cells correlates with microbiota alterations and disease activity in multiple sclerosis ' () 3 Science Advances : e1700492.

High frequency of intestinal TH17 cells correlates with microbiota alterations and disease activity in multiple sclerosisScience Advances3e1700492)| false
• Search Google Scholar

Evrensel, A. and Ceylan, M.E., 2016. Fecal microbiota transplantation and its usage in neuropsychiatric disorders. Clinical Psychopharmacology and Neuroscience 14: 231-237.

'Fecal microbiota transplantation and its usage in neuropsychiatric disorders ' () 14 Clinical Psychopharmacology and Neuroscience : 231 -237.

Fecal microbiota transplantation and its usage in neuropsychiatric disordersClinical Psychopharmacology and Neuroscience14231237)| false
• Search Google Scholar

Ezendam, J., De Klerk, A., Gremmer, E.R. and Van Loveren, H., 2008. Effects of Bifidobacterium animalis administered during lactation on allergic and autoimmune responses in rodents. Clinical and Experimental Immunology 154: 424-431.

'Effects of Bifidobacterium animalis administered during lactation on allergic and autoimmune responses in rodents ' () 154 Clinical and Experimental Immunology : 424 -431.

Effects of Bifidobacterium animalis administered during lactation on allergic and autoimmune responses in rodentsClinical and Experimental Immunology154424431)| false
• Search Google Scholar

Farrokhi, V., Nemati, R., Nichols, F.C., Yao, X., Anstadt, E., Fujiwara, M., Grady, J., Wakefield, D., Castro, W., Donaldson, J. and Clark, R.B., 2013. Bacterial lipodipeptide, Lipid 654, is a microbiome-associated biomarker for multiple sclerosis. Clinical and Translational Immunology 2: e8.

'Bacterial lipodipeptide, Lipid 654, is a microbiome-associated biomarker for multiple sclerosis ' () 2 Clinical and Translational Immunology : e8.

Bacterial lipodipeptide, Lipid 654, is a microbiome-associated biomarker for multiple sclerosisClinical and Translational Immunology2e8)| false
• Search Google Scholar

Fleming, J.O., Isaak, A., Lee, J.E., Luzzio, C.C., Carrithers, M.D., Cook, T.D., Field, A.S., Boland, J. and Fabry, Z., 2011. Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study. Multiple Sclerosis 17: 743-754.

'Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study ' () 17 Multiple Sclerosis : 743 -754.

Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 studyMultiple Sclerosis17743754)| false
• Search Google Scholar

Forbes, J.D., Domselaar, G.V. and Bernstein, C.N., 2016. The gut microbiota in immune-mediated inflammatory diseases. Frontiers in Microbiology 7: 1081.

'The gut microbiota in immune-mediated inflammatory diseases ' () 7 Frontiers in Microbiology : 1081.

The gut microbiota in immune-mediated inflammatory diseasesFrontiers in Microbiology71081)| false
• Search Google Scholar

Furusawa, Y., Obata, Y., Fukuda, S., Endo, T.A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., Takahashi, M., Fukuda, N.N., Murakami, S., Miyauchi, E., Hino, S., Atarashi, K., Onawa, S., Fujimura, Y., Lockett, T., Clarke, J.M., Topping, D.L., Tomita, M., Hori, S., Ohara, O., Morita, T., Koseki, H., Kikuchi, J., Honda, K., Hase, K. and Ohno, H., 2013. Commensal microbederived butyrate induces the differentiation of colonic regulatory T cells. Nature 504: 446-450.

'Commensal microbederived butyrate induces the differentiation of colonic regulatory T cells ' () 504 Nature : 446 -450.

Commensal microbederived butyrate induces the differentiation of colonic regulatory T cellsNature504446450)| false
• Search Google Scholar

Gough, E., Shaikh, H. and Manges, A.R., 2011. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clinical Infectious Diseases 53: 994-1002.

'Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection ' () 53 Clinical Infectious Diseases : 994 -1002.

Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infectionClinical Infectious Diseases539941002)| false
• Search Google Scholar

Hughes, L.E., Smith, P.A., Bonell, S., Natt, R.S., Wilson, C., Rashid, T., Amor, S., Thompson, E.J., Croker, J. and Ebringer, A., 2003. Cross-reactivity between related sequences found in Acinetobacter sp., Pseudomonas aeruginosa, myelin basic protein and myelin oligodendrocyte glycoprotein in multiple sclerosis. Journal of Neuroimmunology 144: 105-115.

'Cross-reactivity between related sequences found in Acinetobacter sp., Pseudomonas aeruginosa, myelin basic protein and myelin oligodendrocyte glycoprotein in multiple sclerosis ' () 144 Journal of Neuroimmunology : 105 -115.

Cross-reactivity between related sequences found in Acinetobacter sp., Pseudomonas aeruginosa, myelin basic protein and myelin oligodendrocyte glycoprotein in multiple sclerosisJournal of Neuroimmunology144105115)| false
• Search Google Scholar

Jangi, S., Gandhi, R., Cox, L.M., Li, N., Von Glehn, F., Yan, R., Patel, B., Mazzola, M.A., Liu, S., Glanz, B.L., Cook, S., Tankou, S., Stuart, F., Melo, K., Nejad, P., Smith, K., Topçuolu, B.D., Holden, J., Kivisäkk, P., Chitnis, T., De Jager, P.L., Quintana, F.J., Gerber, G.K., Bry, L. and Weiner, H.L., 2016. Alterations of the human microbiome in multiple sclerosis. Nature Communications 28: 12015.

'Alterations of the human microbiome in multiple sclerosis ' () 28 Nature Communications : 12015.

Alterations of the human microbiome in multiple sclerosisNature Communications2812015)| false
• Search Google Scholar

Kasper, L.H. and Shoemaker, J., 2010. Multiple sclerosis immunology: the healthy immune system vs the MS immune system. Neurology 5, Suppl. 1: S2-S8.

'Multiple sclerosis immunology: the healthy immune system vs the MS immune system ' () 1 Neurology : S2 -S8.

Multiple sclerosis immunology: the healthy immune system vs the MS immune systemNeurology1S2S8)| false
• Search Google Scholar

Kelly, C.R., De Leon, L. and Jasutkar, N., 2012. Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results. Journal of Clinical Gastroenterology 46: 145-149.

'Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results ' () 46 Journal of Clinical Gastroenterology : 145 -149.

Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and resultsJournal of Clinical Gastroenterology46145149)| false
• Search Google Scholar

Liu, R., Hong, J., Xu, X., Feng, Q., Zhang, D., Gu, Y., Shi, J., Zhao, S., Liu, W., Wang, X., Xia, H., Liu, Z., Cui, B., Liang, P., Xi, L., Jin, J., Ying, X., Wang, X., Zhao, X., Li, W., Jia, H., Lan, Z., Li, F., Wang, R., Sun, Y., Yang, M., Shen, Y., Jie, Z., Li, J., Chen, X., Zhong, H., Xie, H., Zhang, Y., Gu, W., Deng, X., Shen, B., Xu, X., Yang, H., Xu, G., Bi, Y., Lai, S., Wang, J., Qi, L., Madsen, L., Wang, J., Ning, G., Kristiansen, K. and Wang, W., 2017. Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention. Nature Medicine 23: 859-868.

'Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention ' () 23 Nature Medicine : 859 -868.

Gut microbiome and serum metabolome alterations in obesity and after weight-loss interventionNature Medicine23859868)| false
• Search Google Scholar

Metz, L.M., Li, D.K.B., Traboulsee, A.L., Duquette, P., Eliasziw, M., Cerchiaro, G., Greenfield, J., Riddehough, A., Yeung, M., Kremenchutzky, M., Vorobeychik, G., Freedman, M.S., Bhan, V., Blevins, G., Marriott, J.J., Grand’Maison, F., Lee, L., Thibault, M., Hill, M.D., Yong, V.W. and Minocycline in MS Study Team, 2017. Trial of minocycline in a clinically isolated syndrome of multiple sclerosis. New England Journal of Medicine 376: 2122-2133.

'Trial of minocycline in a clinically isolated syndrome of multiple sclerosis ' () 376 New England Journal of Medicine : 2122 -2133.

Trial of minocycline in a clinically isolated syndrome of multiple sclerosisNew England Journal of Medicine37621222133)| false
• Search Google Scholar

Millan, B., Laffin, M. and Madsen, K., 2017. Fecal microbiota transplantation: beyond Clostridium difficile. Current Infectious Disease Report 19: 31.

'Fecal microbiota transplantation: beyond Clostridium difficile ' () 19 Current Infectious Disease Report : 31.

Fecal microbiota transplantation: beyond Clostridium difficileCurrent Infectious Disease Report1931)| false
• Search Google Scholar

Mills, K.H., 2011. TLR-dependent T cell activation in autoimmunity. Nature Reviews Immunology 11: 807-822.

'TLR-dependent T cell activation in autoimmunity ' () 11 Nature Reviews Immunology : 807 -822.

TLR-dependent T cell activation in autoimmunityNature Reviews Immunology11807822)| false
• Search Google Scholar

Miyake, S., Kim, S., Suda, W., Oshima, K., Nakamura, M., Matsuoka, T., Chihara, N., Tomita, A., Sato, W., Kim, S.W., Morita, H., Hattori, M. and Yamamura, T., 2015. Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to Clostridia XIVa and IV clusters. PLoS ONE 10: e0137429.

'Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to Clostridia XIVa and IV clusters ' () 10 PLoS ONE : e0137429.

Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to Clostridia XIVa and IV clustersPLoS ONE10e0137429)| false
• Search Google Scholar

Perkins, D.J., Polumuri, S.K., Pennini, M.E., Lai, W., Xie, P. and Vogel, S.N., 2013. Reprogramming of murine macrophages through TLR2 confers viral resistance via TRAF3-mediated, enhanced interferon production. PLoS Pathogens 9: e1003479.

'Reprogramming of murine macrophages through TLR2 confers viral resistance via TRAF3-mediated, enhanced interferon production ' () 9 PLoS Pathogens : e1003479.

Reprogramming of murine macrophages through TLR2 confers viral resistance via TRAF3-mediated, enhanced interferon productionPLoS Pathogens9e1003479)| false
• Search Google Scholar

Pierrot-Deseilligny, C. and Souberbielle, J.C., 2017. Vitamin D and multiple sclerosis: an update. Multiple Sclerosis Related Disorders 14: 35-45.

'Vitamin D and multiple sclerosis: an update ' () 14 Multiple Sclerosis Related Disorders : 35 -45.

Vitamin D and multiple sclerosis: an updateMultiple Sclerosis Related Disorders143545)| false
• Search Google Scholar

Pröbstel, A.K. and Baranzini, S.E., 2017. The role of the gut microbiome in multiple sclerosis risk and progression: towards characterization of the ‘MS microbiome’. Neurotherapeutics 15: 126-134.

'The role of the gut microbiome in multiple sclerosis risk and progression: towards characterization of the ‘MS microbiome’ ' () 15 Neurotherapeutics : 126 -134.

The role of the gut microbiome in multiple sclerosis risk and progression: towards characterization of the ‘MS microbiome’Neurotherapeutics15126134)| false
• Search Google Scholar

Sabatino Jr. and Zamvil, S.S., 2017. Aryl hydrocarbon receptor activity may serve as a surrogate marker for MS disease activity. Neurology Neuroimmunolgy and Neuroinflammation 4: e366.

'Aryl hydrocarbon receptor activity may serve as a surrogate marker for MS disease activity ' () 4 Neurology Neuroimmunolgy and Neuroinflammation : e366.

Aryl hydrocarbon receptor activity may serve as a surrogate marker for MS disease activityNeurology Neuroimmunolgy and Neuroinflammation4e366)| false
• Search Google Scholar

Salehipour, Z., Haghmorad, D., Sankian, M., Rastin, M., Nosratabadi, R., Soltan Dallal, M.M., Tabasi, N., Khazaee, M., Nasiraii, L.R. and Mahmoudi, M., 2017. Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance. Biomedicine and Pharmacotherapy 95: 1535-1548.

'Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance ' () 95 Biomedicine and Pharmacotherapy : 1535 -1548.

Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balanceBiomedicine and Pharmacotherapy9515351548)| false
• Search Google Scholar

Saresella, M., Mendozzi, L., Rossi, V., Mazzali, F., Piancone, F., LaRosa, F., Marventano, I., Caputo, D., Felis, G.E. and Clerici, M., 2017. Immunological and clinical effect of diet modulation of the gut microbiome in multiple sclerosis patients: a pilot study. Frontiers in Immunology 8: 1391.

'Immunological and clinical effect of diet modulation of the gut microbiome in multiple sclerosis patients: a pilot study ' () 8 Frontiers in Immunology : 1391.

Immunological and clinical effect of diet modulation of the gut microbiome in multiple sclerosis patients: a pilot studyFrontiers in Immunology81391)| false
• Search Google Scholar

Smits, L.P., Bouter, K.E., De Vos, W.M., Borody, T.J. and Nieuwdorp, M., 2013. Therapeutic potential of fecal microbiota transplantation. Gastroenterology 145: 946-953.

'Therapeutic potential of fecal microbiota transplantation ' () 145 Gastroenterology : 946 -953.

Therapeutic potential of fecal microbiota transplantationGastroenterology145946953)| false
• Search Google Scholar

Swidsinski, A., Dörffel, Y., Loening-Baucke, V., Gille, C., Göktas, Ö., Reiβhauer, A., Neuhaus, J., Weylandt, K.H., Guschin, A. and Bock, M., 2017. Reduced mass and diversity of the colonic microbiome in patients with multiple sclerosis and their improvement with ketogenic diet. Frontiers in Microbiology 28: 1141.

'Reduced mass and diversity of the colonic microbiome in patients with multiple sclerosis and their improvement with ketogenic diet ' () 28 Frontiers in Microbiology : 1141.

Reduced mass and diversity of the colonic microbiome in patients with multiple sclerosis and their improvement with ketogenic dietFrontiers in Microbiology281141)| false
• Search Google Scholar

Tremlett, H., Fadrosh, D.W., Faruqi, A.A., Hart, J., Roalstad, S., Graves, J., Lynch, S., Waubant, E. and US Network of Pediatric MS Centers, 2016. Gut microbiota composition and relapse risk in pediatric MS: a pilot study. Journal of the Neurological Science 15: 153-157.

'Gut microbiota composition and relapse risk in pediatric MS: a pilot study ' () 15 Journal of the Neurological Science : 153 -157.

Gut microbiota composition and relapse risk in pediatric MS: a pilot studyJournal of the Neurological Science15153157)| false
• Search Google Scholar

Wang, S., Xu, M., Wang, W., Cao, X., Piao, M., Khan, S., Yan, F., Cao, H. and Wang, B., 2016. Systematic review: adverse events of fecal microbiota transplantation. PLoS ONE 11: e0161174.

'Systematic review: adverse events of fecal microbiota transplantation ' () 11 PLoS ONE : e0161174.

Systematic review: adverse events of fecal microbiota transplantationPLoS ONE11e0161174)| false
• Search Google Scholar

Xu, M.Q., Cao, H.L., Wang, W.Q., Wang, S., Cao, X.C., Yan, F. and Wang, B.M., 2015. Fecal microbiota transplantation broadening its application beyond intestinal disorders. World Journal of Gastroenterology 21: 102-111.

'Fecal microbiota transplantation broadening its application beyond intestinal disorders ' () 21 World Journal of Gastroenterology : 102 -111.

Fecal microbiota transplantation broadening its application beyond intestinal disordersWorld Journal of Gastroenterology21102111)| false
• Search Google Scholar

Yadav, V., Marracci, G., Kim, E., Spain, R., Cameron, M., Overs, S., Riddehough, A., Li, D.K., McDougall, J., Lovera, J., Murchison, C. and Bourdette, D., 2016. Low-fat, plant-based diet in multiple sclerosis: a randomized controlled trial. Multiple Sclerosis Related Disorders 9: 80-90.

'Low-fat, plant-based diet in multiple sclerosis: a randomized controlled trial ' () 9 Multiple Sclerosis Related Disorders : 80 -90.

Low-fat, plant-based diet in multiple sclerosis: a randomized controlled trialMultiple Sclerosis Related Disorders98090)| false
• Search Google Scholar

Zabad, R.K., Metz, L.M., Todoruk, T.R., Zhang, Y., Mitchell, J.R., Yeung, M., Patry, D.G., Bell, R.B. and Yong, V.W., 2007. The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study. Multiple Sclerosis 13: 517-526.

'The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study ' () 13 Multiple Sclerosis : 517 -526.

The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot studyMultiple Sclerosis13517526)| false
• Search Google Scholar

Zhang, J., Ni, J., Chen, Z.H., Li, X., Zhang, R.J., Tang, W., Zhao, W.M., Yang, Y.F. and Zuo, J.P., 2009. Periplocoside A prevents experimental autoimmune encephalomyelitis by suppressing IL-17 production and inhibits differentiation of Th17 cells. Acta Pharmacologica Sinica 30: 1144-1152.

'Periplocoside A prevents experimental autoimmune encephalomyelitis by suppressing IL-17 production and inhibits differentiation of Th17 cells ' () 30 Acta Pharmacologica Sinica : 1144 -1152.

Periplocoside A prevents experimental autoimmune encephalomyelitis by suppressing IL-17 production and inhibits differentiation of Th17 cellsActa Pharmacologica Sinica3011441152)| false
• Search Google Scholar

Zheng, L., Kelly, C.J., Battista, K.D., Schaefer, R., Lanis, J.M., Alexeev, E.E., Wang, R.X., Onyiah, J.C., Kominsky, D.J. and Colgan, S.P., 2017. Microbial-derived butyrate promotes epithelial barrier function through IL-10 receptor-dependent repression of claudin-2. Journal of Immunology 199: 2976-2984.

'Microbial-derived butyrate promotes epithelial barrier function through IL-10 receptor-dependent repression of claudin-2 ' () 199 Journal of Immunology : 2976 -2984.

Microbial-derived butyrate promotes epithelial barrier function through IL-10 receptor-dependent repression of claudin-2Journal of Immunology19929762984)| false
• Search Google Scholar